Cord Blood America, Inc. (CBAI.OB) Details its Business Strategy for 2010
Cord Blood America, Inc., (“CBA”) parent company of CorCell, the first licensed private cord blood bank in the United States, detailed its 2010 business strategy today in an interview posted at their corporate site. The interview explains CBA’s move to a new location, where corporate offices and an important new laboratory are being finalized. It also discusses the company’s finances and success stories for 2009. CBA, through its wholly-owned subsidiary CorCell, collects, tests, processes and stores umbilical cord blood for use in stem cell therapy. This is an innovative approach to health insurance, offering customers the ability to protect their…